Showing posts with label Targeted Delivery of Stem Cells. Show all posts
Showing posts with label Targeted Delivery of Stem Cells. Show all posts

Sunday, March 26, 2017

Targeted Delivery of Our UCB Derived hMSCs

Liver-targeting Delivery via Intravenous Injection of Cells

Check out how our UCB Human Mesenchymal Stem Cells are engineered for delivery to the liver: Hahn, Sei Kwang (Pohang-si, KR), Kim, Yun Seop (Seoul, KR), Kong, Won Ho (Pohang-si, KR),Kim, Hyemin (Daegu, KR). HYALURONIC ACID DERIVATIVES AND COMPOSITION FOR CELL-SURFACE ENGINEERING USING THE SAME. United States Patent Application 20170067012.
Images: Neuromics' hMSCS in culture
Preparation method of a hyaluronic acid derivative capable of modifying the surface of cells and also having biocompatibility, biodegradability, and liver-targeting deliver property, and use of the hyaluronic acid derivative prepared thereby as a liver-targeting cell delivery system.